Publications en collaboration avec des chercheurs de Hospital Universitario 12 de Octubre (27)

2023

  1. Finerenone protects against progression of kidney and cardiovascular damage in a model of type 1 diabetes through modulation of proinflammatory and osteogenic factors

    Biomedicine and Pharmacotherapy, Vol. 168

  2. Imbalance in Bone Morphogenic Proteins 2 and 7 Is Associated with Renal and Cardiovascular Damage in Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Intervention by a clinical pharmacist carried out at discharge of elderly patients admitted to the internal medicine department: influence on readmissions and costs

    BMC Health Services Research, Vol. 22, Núm. 1

  2. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

    JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560

2020

  1. Beneficial effects of paricalcitol on cardiac dysfunction and remodelling in a model of established heart failure

    British Journal of Pharmacology, Vol. 177, Núm. 14, pp. 3273-3290

  2. Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

    American Journal of Nephrology, Vol. 51, Núm. 4, pp. 294-303

2018

  1. Deficiency of NOD1 improves the β-adrenergic modulation of Ca2+ handling in a mouse model of heart failure

    Frontiers in Physiology, Vol. 9, Núm. JUN

  2. Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress

    Frontiers in Pharmacology, Vol. 9, Núm. OCT

2017

  1. Drug syrups: Errors in drug labels with possible consequences in patients with heritary fructose intolerance

    Anales de Pediatria, Vol. 87, Núm. 6, pp. 351-353

  2. Identification of new SNPs associated with severe toxicity to capecitabine

    Pharmacological Research, Vol. 120, pp. 133-137

  3. Mild and short-term caloric restriction prevents obesity-induced cardiomyopathy in young zucker rats without changing in metabolites and fatty acids cardiac profile

    Frontiers in Physiology, Vol. 8, Núm. FEB

  4. Rapid, automated, and specific immunoassay to directly measure matrix metalloproteinase-9-tissue inhibitor of metalloproteinase-1 interactions in human plasma using AlphaLISA technology: A new alternative to classical ELISA

    Frontiers in Immunology, Vol. 8, Núm. JUL

  5. Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling

    Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 423-433

  6. Use of exome sequencing to determine the full profile of genetic variants in the fluoropyrimidine pathway in colorectal cancer patients affected by severe toxicity

    Pharmacogenomics, Vol. 18, Núm. 13, pp. 1215-1223

2016

  1. Global cardiovascular protection in chronic kidney disease

    Nature Reviews Cardiology, Vol. 13, Núm. 10, pp. 603-608

  2. Role of matrix metalloproteinase-9 in chronic kidney disease: A new biomarker of resistant albuminuria

    Clinical Science, Vol. 130, Núm. 7, pp. 525-538

2015

  1. Fetal undernutrition is associated with perinatal sex-dependent alterations in oxidative status

    Journal of Nutritional Biochemistry, Vol. 26, Núm. 12, pp. 1650-1659

  2. Genetic predisposition to albuminuria is associated with increased arterial stiffness: Role of elastin

    British Journal of Pharmacology, Vol. 172, Núm. 17, pp. 4406-4418

  3. High-fat diet induces endothelial dysfunction through a down-regulation of the endothelial AMPK-PI3K-Akt-eNOS pathway

    Molecular Nutrition and Food Research, Vol. 59, Núm. 3, pp. 520-532

  4. NOD1, a new player in cardiac function and calcium handling

    Cardiovascular Research, Vol. 106, Núm. 3, pp. 375-386